(Q37401252)

20 August 2017

Anti-IgE treatment of eosinophil-associated gastrointestinal disorders (English)

1 reference

20 August 2017

7

Dean D Metcalfe

1 reference

20 August 2017

Shabnam Foroughi

1

1 reference

20 August 2017

Barbara Foster

2

1 reference

20 August 2017

Nayoung Kim

3

1 reference

20 August 2017

Leigh B Bernardino

4

1 reference

20 August 2017

Linda M Scott

5

1 reference

20 August 2017

Robert G Hamilton

6

1 reference

20 August 2017

Peter J Mannon

8

1 reference

20 August 2017

Calman Prussin

9

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

The Journal of Allergy and Clinical Immunology

20 August 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 August 2017

120

1 reference

20 August 2017

3

1 reference

20 August 2017

594-601

1 reference

Eosinophilic esophagitis: pathogenesis, genetics, and therapy

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Evaluation of basophil activation in food allergy: present and future applications.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Omalizumab-induced reductions in mast cell Fce psilon RI expression and function

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Eosinophilic gastrointestinal disorders (EGID).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Omalizumab treatment downregulates dendritic cell FcepsilonRI expression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Effect of anti-IgE therapy in patients with peanut allergy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

The Crohn's Disease Activity Index, its derivatives and the Inflammatory Bowel Disease Questionnaire: a review of instruments to assess Crohn's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Evidence of in vivo basophil activation in chronic idiopathic urticaria

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Human dendritic cell 1 and dendritic cell 2 subsets express FcepsilonRI: correlation with serum IgE and allergic asthma

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Immunological and clinical changes in allergic asthmatics following treatment with omalizumab

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768344

The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17765756

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Analysis of anti-IgE and allergen induced human basophil activation by flow cytometry. Comparison with histamine release

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17765756

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JACI.2007.06.015

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

17765756

1 reference